Clinical trial
Efficacy and Safety of Escin as add-on Treatment in Covid-19 Infected Patients
NCT04322344 is registered in ClinicalTrials.gov with University of Catanzaro as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Escin as add-on Treatment in Covid-19 Infected Patients
- Lead sponsor
- University of Catanzaro
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- March 23, 2020
- Completion date
- December 30, 2020
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.